Compare USPH & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USPH | SDGR |
|---|---|---|
| Founded | 1990 | 1990 |
| Country | United States | United States |
| Employees | 5500 | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 856.7M |
| IPO Year | 1996 | 2020 |
| Metric | USPH | SDGR |
|---|---|---|
| Price | $82.59 | $12.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $106.50 | $24.33 |
| AVG Volume (30 Days) | 208.2K | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $780,990,000.00 | $255,869,000.00 |
| Revenue This Year | $9.20 | $23.92 |
| Revenue Next Year | $5.73 | $19.52 |
| P/E Ratio | $58.30 | ★ N/A |
| Revenue Growth | 16.33 | ★ 23.29 |
| 52 Week Low | $62.77 | $11.11 |
| 52 Week High | $93.50 | $27.63 |
| Indicator | USPH | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 43.55 |
| Support Level | $81.46 | $11.11 |
| Resistance Level | $88.69 | $19.51 |
| Average True Range (ATR) | 3.28 | 0.80 |
| MACD | -0.48 | 0.25 |
| Stochastic Oscillator | 51.74 | 50.57 |
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.